• NIH scientists discover molecule triggers sensation of itchNIH scientists discover molecule triggers sensation of itch

    NIH scientists discover molecule triggers sensation of itch

    Friday, 24 May 2013

    Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.

  • FDA allows marketing of first A1c test labeled for diagnosing diabetesFDA allows marketing of first A1c test labeled for diagnosing diabetes

    FDA allows marketing of first A1c test labeled for diagnosing diabetes

    Friday, 24 May 2013

    Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use.

  • How we work out: Stiff Guy YogaHow we work out: Stiff Guy Yoga

    How we work out: Stiff Guy Yoga

    Friday, 24 May 2013

    "Stiff Guy Yoga" may sound humorous, but these guys take their workout seriously. And they should. Because when done properly, yoga helps alleviate tightness, tones the body and relieves stress.

  • Suppressing protein may stem Alzheimer's disease processSuppressing protein may stem Alzheimer's disease process

    Suppressing protein may stem Alzheimer's disease process

    Thursday, 25 April 2013

    Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer’s disease. It’s based on unclogging removal of toxic debris that accumulates in patients’ brains, by blocking activity of a little-known regulator protein called CD33.

  • Emergency response to antimalarial drug resistanceEmergency response to antimalarial drug resistance

    Emergency response to antimalarial drug resistance

    Thursday, 25 April 2013

    25 April 2013 – On World Malaria Day, WHO recognizes significant accomplishments in preventing and controlling malaria, but highlights the threat of antimalarial drug resistance in south-east Asia’s Greater Mekong subregion. WHO is launching a new Emergency Response to Artemisinin Resistance in Phnom Penh, Cambodia. The emergency response framework will guide a major scale-up of WHO-recommended strategies to combat this public health threat.

  • FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection toolFDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool

    FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool

    Thursday, 25 April 2013

    The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.

  • CareFirst proposes 25 percent rate increase under health care reformCareFirst proposes 25 percent rate increase under health care reform

    CareFirst proposes 25 percent rate increase under health care reform

    Thursday, 25 April 2013

    Blaming the cost to implement health care reform, the state's largest health insurer has proposed eye-popping rate increases to state regulators for individuals and small businesses.

  • 5 ways to live healthier, longer5 ways to live healthier, longer

    5 ways to live healthier, longer

    Thursday, 25 April 2013

    There are dozens of anti-aging gimmicks out there – but the real secret to turning back the hands of time lies in a healthy lifestyle.

  • Anti-HIV therapy appears to protect children's hearts, NIH network study showsAnti-HIV therapy appears to protect children's hearts, NIH network study shows

    Anti-HIV therapy appears to protect children's hearts, NIH network study shows

    Tuesday, 23 April 2013

    For children who have had HIV-1 infection since birth, the combination drug therapies now used to treat HIV appear to protect against the heart damage seen before combination therapies were available, according to researchers in a National Institutes of Health network study.

  • Vaccinating Roma children in BulgariaVaccinating Roma children in Bulgaria

    Vaccinating Roma children in Bulgaria

    Tuesday, 23 April 2013

    23 April 2013 – WHO’s innovative new "Guide to Tailoring Immunization Programmes", successfully pilot tested in Bulgaria, helps countries reach children in vulnerable communities. World Immunization Week, that began 20 April, promotes one of the world’s most powerful tools for health – the use of vaccines to protect, or "immunize", people of all ages against disease.